Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy
Abstract
Objective:
Methods:
Results:
Conclusions:
Level of evidence:
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
- Download
- 29.50 KB
REFERENCES
Information & Authors
Information
Published In
Copyright
Publication History
Disclosure
Study Funding
Authors
Author Contributions
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Prospect of novel therapies in immune-mediated neuropathies免疫介在性ニューロパチーの新規治療展望, Rinsho Shinkeigaku, 64, 1, (1-7), (2024).https://doi.org/10.5692/clinicalneurol.cn-001888
- Therapeutic Outcomes and Electrophysiological Biomarkers in Anti-Myelin-Associated Glycoprotein Neuropathy: A Multicenter Cohort Study in South Korea, Journal of Clinical Neurology, 20, 1, (50), (2024).https://doi.org/10.3988/jcn.2023.0127
- Optimizing Anti–Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation, Neurology, 103, 11, (2024)./doi/10.1212/WNL.0000000000210000
- Prevalence and clinical profiles of anti‐ myelin‐associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients , European Journal of Neurology, 31, 5, (2024).https://doi.org/10.1111/ene.16249
- Rituximab with alkylating agent in anti‐myelin‐associated glycoprotein neuropathy: A retrospective study of 26 cases, British Journal of Haematology, 204, 6, (2484-2486), (2024).https://doi.org/10.1111/bjh.19412
- Top 10 Clinical Pearls in Paraproteinemic Neuropathies, Seminars in Neurology, (2024).https://doi.org/10.1055/s-0044-1791769
- Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials, Arquivos de Neuro-Psiquiatria, 82, 06, (001-007), (2024).https://doi.org/10.1055/s-0043-1777728
- Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS, Heliyon, 10, 7, (e28870), (2024).https://doi.org/10.1016/j.heliyon.2024.e28870
- Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?, Hematopoietic Stem Cell Transplantation for Neurologic Diseases, (199-238), (2024).https://doi.org/10.1016/B978-0-323-90242-7.00002-X
- Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders, Paraneoplastic Neurologic Disorders, (239-273), (2024).https://doi.org/10.1016/B978-0-12-823912-4.00020-7
- See more
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.